Clinical Trial Update: Interleukin23 in Systemic Lupus [NA]

View source ↗

Summary

A clinical trial is recruiting at Sohag University to evaluate interleukin-23 in systemic lupus erythematosus with interstitial lung disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Lung Disease
• Systemic Lupus Erythematosus

Drugs mentioned

• Interleukin-23 (interleukin-23)

Snippet

Sponsor: Sohag University | Conditions: Systemic Lupus Erythematosus Related Interstial Lung Disease | NA | Status: RECRUITING